The Evolving Role of Immunotherapy in Stage III Non-Small Cell Lung Cancer

The management of Stage III non-small cell lung cancer (NSCLC) is complex and requires multidisciplinary input. Since the publication of the PACIFIC trial (consolidative durvalumab post concurrent chemotherapy and radiation in Stage III disease) which showed improved survival for patients in the imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Perdrizet, Kirstin, Cheema, Parneet K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700596/
https://www.ncbi.nlm.nih.gov/pubmed/34940090
http://dx.doi.org/10.3390/curroncol28060451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700596/
https://www.ncbi.nlm.nih.gov/pubmed/34940090
http://dx.doi.org/10.3390/curroncol28060451

Ejemplares similares